Literature DB >> 22907857

Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.

Konen Obayashi1, Mitsuharu Ueda, Toshinori Oshima, Satomi Kawahara, Yohei Misumi, Taro Yamashita, Hirofumi Jono, Masahide Yazaki, Fuyuki Kametani, Shu-ichi Ikeda, Yuki Ohya, Katsuhiro Asonuma, Yukihiro Inomata, Yukio Ando.   

Abstract

Liver transplantation (LT) reportedly prolongs the survival of patients with familial amyloidotic polyneuropathy (FAP), a fatal hereditary systemic amyloidosis caused by mutant transthyretin (TTR). However, what happens in systemic tissue sites long after LT is poorly understood. In the present study, we report pathological and biochemical findings for an FAP patient who underwent LT and died from refractory ventricular fibrillation more than 16 years after FAP onset. Our autopsy study revealed that the distributions of amyloid deposits after LT were quite different from those in FAP amyloidogenic TTR V30M patients not having had LT and seemed to be similar to those observed in senile systemic amyloidosis (SSA), a sporadic systemic amyloidosis derived from wild-type (WT) TTR. Our biochemical examination also revealed that this patient's cardiac and tongue amyloid deposits derived mostly from WT TTR. We propose that FAP patients after LT may suffer from SSA-like WT TTR amyloidosis in systemic organs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22907857      PMCID: PMC4543899          DOI: 10.1136/bcr-2012-006593

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients.

Authors:  M Yazaki; S Mitsuhashi; T Tokuda; F Kametani; Y-I Takei; J Koyama; A Kawamorita; H Kanno; S-I Ikeda
Journal:  Am J Transplant       Date:  2006-10-25       Impact factor: 8.086

Review 2.  Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature.

Authors:  Aimee M Morris; Murielle A Watzky; Richard G Finke
Journal:  Biochim Biophys Acta       Date:  2008-11-11

3.  Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.

Authors:  Haruki Koike; Yukio Ando; Mitsuharu Ueda; Yuichi Kawagashira; Masahiro Iijima; Junko Fujitake; Michiyuki Hayashi; Masahiko Yamamoto; Eiichiro Mukai; Tomohiko Nakamura; Masahisa Katsuno; Naoki Hattori; Gen Sobue
Journal:  J Neurol Sci       Date:  2009-08-25       Impact factor: 3.181

Review 4.  Transthyretin-related familial amyloidotic polyneuropathy.

Authors:  Yukio Ando; Masaaki Nakamura; Shukuro Araki
Journal:  Arch Neurol       Date:  2005-07

5.  Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy.

Authors:  T Yamashita; Y Ando; S Okamoto; Y Misumi; T Hirahara; M Ueda; K Obayashi; M Nakamura; H Jono; M Shono; K Asonuma; Y Inomata; M Uchino
Journal:  Neurology       Date:  2012-02-15       Impact factor: 9.910

6.  Progression of ventricular wall thickening after liver transplantation for familial amyloidosis.

Authors:  S W Dubrey; R Davidoff; M Skinner; P Bergethon; D Lewis; R H Falk
Journal:  Transplantation       Date:  1997-07-15       Impact factor: 4.939

7.  Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.

Authors:  Mitsuharu Ueda; Yoko Horibata; Makoto Shono; Yohei Misumi; Toshinori Oshima; Yu Su; Masayoshi Tasaki; Satoru Shinriki; Satomi Kawahara; Hirofumi Jono; Konen Obayashi; Hisao Ogawa; Yukio Ando
Journal:  Mod Pathol       Date:  2011-08-05       Impact factor: 7.842

8.  Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy.

Authors:  H Koike; K Misu; M Sugiura; M Iijima; K Mori; M Yamamoto; N Hattori; E Mukai; Y Ando; S Ikeda; G Sobue
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

9.  Senile systemic amyloidosis.

Authors:  P Pitkänen; P Westermark; G G Cornwell
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

10.  Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan: a clinicopathologic, histochemical, immunohistochemical, and ultrastructural study.

Authors:  K Takahashi; S Yi; Y Kimura; S Araki
Journal:  Hum Pathol       Date:  1991-06       Impact factor: 3.466

View more
  3 in total

Review 1.  Ocular Manifestations and Therapeutic Options in Patients with Familial Amyloid Polyneuropathy: A Systematic Review.

Authors:  A C Martins; A M Rosa; E Costa; C Tavares; M J Quadrado; J N Murta
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411

2.  Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment.

Authors:  Genki Suenaga; Tokunori Ikeda; Yoshihiro Komohara; Koutaro Takamatsu; Tatsuyuki Kakuma; Masayoshi Tasaki; Yohei Misumi; Mitsuharu Ueda; Takaaki Ito; Satoru Senju; Yukio Ando
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

3.  Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis.

Authors:  Ivana Slamova; Rozita Adib; Stephan Ellmerich; Michal R Golos; Janet A Gilbertson; Nicola Botcher; Diana Canetti; Graham W Taylor; Nigel Rendell; Glenys A Tennent; Guglielmo Verona; Riccardo Porcari; P Patrizia Mangione; Julian D Gillmore; Mark B Pepys; Vittorio Bellotti; Philip N Hawkins; Raya Al-Shawi; J Paul Simons
Journal:  Nat Commun       Date:  2021-12-07       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.